Prostate Cancer
A population-based study of cardiovascular disease mortality risk in US cancer patients.
January 10, 2024
Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC.
January 10, 2024
Assessment of Cell Surface Targets in Metastatic Prostate Cancer: Expression Landscape and Molecular Correlates.
January 10, 2024
Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate Cancer.
January 10, 2024
Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics
January 9, 2024
Safety Analyses of the Phase 3 VISION Trial of [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer.
January 9, 2024
Tissue contamination challenges the credibility of machine learning models in real world digital pathology.
January 9, 2024
Adverse events and costs among non-metastatic castration-resistant prostate cancer patients.
January 8, 2024
Development and validation of a clinical decision support system based on PSA, microRNAs, and MRI for the detection of prostate cancer.
January 8, 2024
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping.
January 8, 2024